Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread

GJC Burkill, M Badran, O Al-Muderis, J Meirion Thomas… - Radiology, 2003 - pubs.rsna.org
PURPOSE: To investigate and describe the anatomic distribution, imaging features, and
pattern of metastatic spread of malignant gastrointestinal stromal tumors (GISTs). MATERIALS …

Differential sensitivity of liposarcoma subtypes to chemotherapy

RL Jones, C Fisher, O Al-Muderis, IR Judson - European journal of cancer, 2005 - Elsevier
Liposarcoma is one of the most common soft tissue sarcomas and has a number of different
subtypes: well-differentiated; dedifferentiated; myxoid/round cell; and pleomorphic. However…

Significant clinical benefit of first‐line palliative chemotherapy in advanced soft‐tissue sarcoma: Retrospective analysis and identification of prognostic factors in 488 …

V Karavasilis, BM Seddon, S Ashley, O AlMuderis… - Cancer, 2008 - Wiley Online Library
BACKGROUND. The efficacy of palliative chemotherapy was investigated in a large group
of patients with advanced soft‐tissue sarcomas (STS) treated on routine palliative protocols. …

[HTML][HTML] Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature

HH Wong, HM Hatcher, C Benson, O Al-Muderis… - Clinical sarcoma …, 2013 - Springer
Background Desmoplastic small round cell tumour (DSRCT) is a rare but frequently fatal
sarcoma, and many of its characteristics still require further clarification. Methods We …

Prognosis of lymph node metastasis in soft tissue sarcoma

KA Behranwala, R A'Hern, AM Omar… - Annals of surgical …, 2004 - Springer
Background: We defined the tumor characteristics and prognosis of patients with regional
lymph node metastasis (RLNM) from soft tissue sarcoma. Methods: All patients with RLNM …

Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis

…, RL Jones, M Scurr, O Al-Muderis… - European journal of …, 2009 - Elsevier
BACKGROUND: Aggressive fibromatosis (AF) or desmoid tumour is a monoclonal proliferation
which is locally invasive but does not metastasize. If local treatment fails to control the …

A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience

…, N Tunariu, S Mitchell, O Al-Muderis… - Anticancer …, 2014 - ar.iiarjournals.org
Perivascular epithelioid cell tumors (PEComas) are rare tumors driven by tuberous sclerosis
complex gene mutations causing up-regulation of mTOR. We report the outcome of ten …

Advanced aggressive fibromatosis: effective palliation with chemotherapy

…, RL Jones, M Scurr, O Al-Muderis… - Acta …, 2011 - Taylor & Francis
Background. Aggressive fibromatosis (AF) is a locally invasive proliferative disease. The
mainstay of treatment is surgery. Chemotherapy may be considered in inoperable AF following …

Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience

N Yousaf, M Maruzzo, I Judson, O Al-Muderis… - Anticancer …, 2015 - ar.iiarjournals.org
Background: Epithelioid haemangioendothelioma (EHE) is a rare vascular tumour, which
can arise at any site. There is little published data about the management of these tumours. …

Role of palliative chemotherapy in advanced epithelioid sarcoma

…, K Thway, C Fisher, O Al-Muderis… - American Journal of …, 2012 - journals.lww.com
Background Epithelioid sarcoma is a rare soft tissue sarcoma subtype. The response of this
disease to chemotherapy is not well described. The aim of this study was to investigate the …